Income Statement Presentation 2023

2022: Good sales growth in both divisions despite COVID-19 headwinds 2022 2021 Change in % CHFbn CHFbn CHF CER Pharmaceuticals Division 45.6 45.0 1 2 Diagnostics Division 17.7 17.8 0 3 Roche Group 63.3 62.8 1 2 CER=Constant Exchange Rates; totals may include differences due to rounding Roche 8

View entire presentation